Finance

Lists
BIOG-B:STO
BioGaia AB
SEK 120.40
+0.42%
(+0.50) 1D
Oct 30, 5:00:00 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOG-B...
Open
SEK 119.60
High
SEK 120.70
Low
SEK 119.30
Mkt. cap
11.86B
Avg. vol.
204.68K
Volume
84.74K
52-wk high
SEK 136.30
52-wk low
SEK 96.20
Shares outstanding
98.50M
No. of employees
251
Open
SEK 119.60
High
SEK 120.70
Low
SEK 119.30
Mkt. cap
11.86B
Avg. vol.
204.68K
Volume
84.74K
52-wk high
SEK 136.30
52-wk low
SEK 96.20
Shares outstanding
98.50M
No. of employees
251
News stories
From web sources and news partners
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB
CEOTheresa Agnew
Employees251
Founded1990
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
440.57M
372.55M
440.86M
400.44M
Cost of goods sold
116.74M
105.77M
119.98M
108.46M
Cost of revenue
116.74M
105.77M
119.98M
108.46M
Research and development expenses
36.79M
25.53M
28.24M
25.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
159.68M
145.89M
167.47M
146.96M
Operating expense
196.47M
171.42M
195.71M
172.92M
Total operating expenses
313.21M
277.19M
315.69M
281.38M
Operating income
127.36M
95.36M
125.17M
119.05M
Other non operating income
-2.39M
285.00K
-1.00K
-
EBT including unusual items
123.58M
101.50M
134.03M
134.27M
EBT excluding unusual items
117.88M
103.78M
134.03M
134.27M
Income tax expense
24.80M
22.10M
30.88M
24.06M
Effective tax rate
20.07%
21.77%
23.04%
17.92%
Other operating expenses
-
-
-
-
Net income
98.78M
79.41M
103.16M
110.21M
Net profit margin
22.42%
21.32%
23.40%
27.52%
Earnings per share
0.98
0.78
1.11
1.09
Interest and investment income
2.81M
2.34M
2.01M
2.04M
Interest expense
-3.49M
-
-62.00K
-383.00K
Net interest expenses
-677.00K
2.34M
1.95M
1.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
133.49M
101.50M
131.21M
125.34M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps